- Home
- MTCH vs LNTH Comparison
MTCH vs LNTH Comparison
Compare MTCH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTCH | LNTH |
|---|---|---|
| Founded | 1986 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 4.4B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MTCH | LNTH |
|---|---|---|
| Price | $32.93 | $65.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $35.27 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 3.1M | 1.1M |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.15 | ★ 2.39 |
| Revenue | ★ $3,469,367,000.00 | $1,525,933,000.00 |
| Revenue This Year | $2.06 | $0.01 |
| Revenue Next Year | $3.46 | $1.24 |
| P/E Ratio | ★ $15.19 | $27.10 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $26.39 | $47.25 |
| 52 Week High | $39.20 | $111.29 |
Technical Indicators
Market Signals| Indicator | MTCH | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 67.15 |
| Support Level | $32.19 | $64.13 |
| Resistance Level | $34.35 | $67.01 |
| Average True Range (ATR) | 0.72 | 2.17 |
| MACD | -0.12 | 0.32 |
| Stochastic Oscillator | 24.41 | 83.73 |
Price Performance
Historical ComparisonAbout MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.